Startup raises $100M to test endoscopic treatment for type 2 diabetes

Lexington's Fractyl Laboratories has rebranded as Fractyl Health and brought in $100 million as it looks to wrap up late-stage trials of a new treatment for Type 2 diabetes.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.